Chagas' cardiomyopathy: The economic burden of an expensive and neglected disease

Imagem de Miniatura
Arquivos
art_ABUHAB_Chagas_cardiomyopathy_The_economic_burden_of_an_expensive_2013.PDF (184.65 KB)
Citações na Scopus
48
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
AULICINO, Gabriel Barros
Citação
INTERNATIONAL JOURNAL OF CARDIOLOGY, v.168, n.3, p.2375-2380, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Chagas' cardiomyopathy (CC) is a rising etiology for heart failure (HF) that previously was restricted to some countries of Latin America. The chronic CC cases cause now a profound socio-economic impact. However this issue has not been well studied if compared to other causes of HF. The objective of this study was to assess the cost burden of CC during acute decompensated HF admissions (ADHF), and compare this cost to the other etiologies of HF. Methods and results: By the end of 2006 we started a five year follow-up of 577 consecutive adult patients admitted at a high complexity cardiology university hospital in the city of Sao Paulo, Brazil. This study shows the data of the first admission of each patient of this follow-up. Patients were divided in two groups: CC (58 patients) and non-chagasic (NC) (519 patients). Mortality was different among groups, 19/58 (32.8%) in CC vs 113/519 (21.8%) in NC (p=0.046). The prevalence of signs of inadequate perfusion was higher in the CC group at admission, but in a multivariated analysis chagasic etiology and presence of diabetes were independent predictors of higher costs per day of hospitalization adjusted by mortality. Median costs per day were US$308 (277-542) vs US$467 (323-815) for NC and CC respectively (p<0.001). Conclusion: Treating ADHF patients with CC etiology was more expensive and mortality was higher in this population at the first admission of this follow-up. This could be explained by the severity of Chagas' cardiomyopathy disease.
Palavras-chave
Chagas' cardiomyopathy, Economic burden, Neglected disease
URI
https://observatorio.fm.usp.br/handle/OPI/3952
Referências
  1. Abraham WT, 2005, J AM COLL CARDIOL, V46, P57, DOI 10.1016/j.jacc.2005.03.051
  2. Araujo Denizar Vianna, 2005, Arq Bras Cardiol, V84, P422, DOI 10.1590/S0066-782X2005000500013
  3. Bocchi EA, 2001, ANN THORAC SURG, V71, P1833, DOI 10.1016/S0003-4975(01)02587-5
  4. Bocchi Edimar Alcides, 2009, Arq Bras Cardiol, V93, P3, DOI 10.1590/S0066-782X2009002000001
  5. Carod-Artal J, 2010, LANCET NEUROL, V9, P533
  6. Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541
  7. Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309
  8. Drummond MF, 2005, METHODS EC EVALUATIO
  9. Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019
  10. Dunlay SM, 2011, CIRC-CARDIOVASC QUAL, V4, P68, DOI 10.1161/CIRCOUTCOMES.110.957225
  11. Ertl G, 2007, CARDIOL CLIN, V25, P487
  12. Freitas HFG, 2005, INT J CARDIOL, V102, P239, DOI 10.1016/j.ijcard.2004.05.025
  13. Garcia VD, TRANSPLANTATION SOC
  14. Gascona CJ, 2010, ACTA TROP, V115, P22
  15. Hanford EJ, 2007, SOC SCI MED, V65, P60, DOI 10.1016/j.socscimed.2007.02.041
  16. Heywood JT, 2007, J CARD FAIL, V13, P422, DOI 10.1016/j.cardfail.2007.03.011
  17. Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013
  18. Kirklin JK, 2012, J HEART LUNG TRANSPL, V31, P117, DOI 10.1016/j.healun.2011.12.001
  19. Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12
  20. Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.00000.39105.49749.6F
  21. Martins M, 2008, CAD SAUDE PUBLICA, V24, P643, DOI 10.1590/S0102-311X2008000300018
  22. Mathers CD, 2007, NEGL TROP DIS, V1, P114
  23. Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005
  24. Neumann T, 2009, DTSCH ARZTEBL INT, V106, P269, DOI 10.3238/arztebl.2009.0269
  25. Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193
  26. Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0375-1097(03)00309-7
  27. Petherick A, 2011, NAT MED, V17, P1174, DOI 10.1038/nm1011-1174a
  28. Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531
  29. Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
  30. Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
  31. Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003
  32. Smith MW, 2010, MICROCOST METHODS DE

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - ODS/03